search query: @author Fallon, P. / total: 8
reference: 1 / 8
« previous | next »
| Author: | Fallon, P. |
| Title: | Doctor Vasella revives Novartis |
| Journal: | Euromoney
2000 : NOV, 379, p. 44-61 |
| Index terms: | MANAGEMENT PHARMACEUTICAL INDUSTRY USA |
| Language: | eng |
| Abstract: | Daniel Vasella has had a tough time as chief executive of life sciences company Novartis, with a collapse in its agribusiness, management turmoil in pharmaceuticals and weak performance in the US. But he's restructured the company and now hopes new drugs can deliver growth. Novartis is subject to constant speculation that it will soon take part in a mega-merger. In a candid interview, Daniel Vasella talked to Padraic Fallon, chairman of Euromoney Institutional Investor, about his successes, his mistakes and his hopes for the future. |
« previous | next »
SCIMA